Ethical Issues Related to Screening for Preeclampsia

Bioethics 28 (7):360-367 (2012)
  Copy   BIBTEX


The implementation of new methods of treating and preventing disease raises many question of both technical and moral character. Currently, many studies focus on developing a screening test for preeclampsia (PE), a disease complicating 2–8% of pregnancies, potentially causing severe consequences for pregnant women and their fetuses. The purpose is to develop a test that can identify pregnancies at high risk for developing PE sufficiently early in pregnancy to allow for prophylaxis. However, the question of implementing a screening test for PE does not only involve an evaluation of technical feasibility and clinical efficacy, it also requires an analysis of how the test influences the conditions and choices for those tested. This study evaluates state-of-the-art techniques for preeclampsia screening in an ethical framework, pointing out the central areas of moral relevance within the context of such screening activity. Furthermore, we propose ethical guidelines that a screening programme for PE should meet in order to become an uncontroversial addition to prenatal health care



    Upload a copy of this work     Papers currently archived: 94,517

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Should we genetically test everyone for haemochromatosis?K. Allen & R. Williamson - 1999 - Journal of Medical Ethics 25 (2):209-214.


Added to PP

41 (#384,624)

6 months
7 (#622,206)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Citations of this work

Reconsidering counselling and consent.David R. Hall & Anton A. Niekerk - 2015 - Developing World Bioethics 17 (1):4-10.

Add more citations

References found in this work

No references found.

Add more references